...
首页> 外文期刊>Respiratory Research >Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization
【24h】

Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization

机译:通过表面声波雾化有效地肺部输送雾化质粒DNA疫苗

获取原文

摘要

BackgroundPulmonary-delivered gene therapy promises to mitigate vaccine safety issues and reduce the need for needles and skilled personnel to use them. While plasmid DNA (pDNA) offers a rapid route to vaccine production without side effects or reliance on cold chain storage, its delivery to the lung has proved challenging. Conventional methods, including jet and ultrasonic nebulizers, fail to deliver large biomolecules like pDNA intact due to the shear and cavitational stresses present during nebulization.MethodsIn vitro structural analysis followed by in vivo protein expression studies served in assessing the integrity of the pDNA subjected to surface acoustic wave (SAW) nebulisation. In vivo immunization trials were then carried out in rats using SAW nebulized pDNA (influenza A, human hemagglutinin H1N1) condensate delivered via intratracheal instillation. Finally, in vivo pulmonary vaccinations using pDNA for influenza was nebulized and delivered via a respirator to sheep.ResultsThe SAW nebulizer was effective at generating pDNA aerosols with sizes optimal for deep lung delivery. Successful gene expression was observed in mouse lung epithelial cells, when SAW-nebulized pDNA was delivered to male Swiss mice via intratracheal instillation. Effective systemic and mucosal antibody responses were found in rats via post-nebulized, condensed fluid instillation. Significantly, we demonstrated the suitability of the SAW nebulizer to administer unprotected pDNA encoding an influenza A virus surface glycoprotein to respirated sheep via aerosolized inhalation.ConclusionGiven the difficulty of inducing functional antibody responses for DNA vaccination in large animals, we report here the first instance of successful aerosolized inhalation delivery of a pDNA vaccine in a large animal model relevant to human lung development, structure, physiology, and disease, using a novel, low-power (<1 W) surface acoustic wave (SAW) hand-held nebulizer to produce droplets of pDNA with a size range suitable for delivery to the lower respiratory airways.
机译:背景技术肺传递基因疗法有望减轻疫苗安全性问题,并减少对针头和熟练人员使用它们的需求。尽管质粒DNA(pDNA)提供了快速的疫苗生产途径,且没有副作用或不依赖冷链存储,但事实证明,将其传递到肺部具有挑战性。常规方法,包括喷射和超声雾化器,由于雾化过程中存在剪切力和空化应力,无法完整传递pDNA之类的大生物分子。方法体外结构分析和体内蛋白质表达研究可用于评估表面pDNA的完整性声波(SAW)雾化。然后使用通过气管内滴注递送的SAW雾化的pDNA(甲型流感,人类血凝素H1N1)浓缩液在大鼠中进行了体内免疫试验。最后,雾化了使用pDNA进行流感的体内肺疫苗接种,并通过呼吸器递送给绵羊。结果SAW雾化器可有效产生大小适合深肺递送的pDNA气雾剂。当通过气管内滴注将SAW雾化的pDNA传递给雄性Swiss小鼠时,在小鼠肺上皮细胞中观察到成功的基因表达。通过雾化后,浓缩液滴注在大鼠中发现了有效的全身和粘膜抗体反应。重要的是,我们证明了SAW雾化器适用于通过雾化吸入向呼吸道绵羊施用编码甲型流感病毒表面糖蛋白的未保护pDNA。结论鉴于给大型动物诱导功能性抗体应答以进行DNA疫苗接种的困难,我们在此报告了第一例使用新型低功率(<1 W)表面声波(SAW)手持式雾化器在与人肺发育,结构,生理和疾病相关的大型动物模型中成功雾化吸入pDNA疫苗pDNA液滴的大小范围适合输送至下呼吸道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号